Niraparib in Patients With Pancreatic Cancer

Clinical trial NCT03601923 · COMPLETED

Trial details

NCT number: NCT03601923
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2018-08-22
Primary completion: 2025-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.